Anti-HIV-1 systemic humoral immunity.
- Veronica Rainone (340775)
- Gregor Dubois (340777)
- Vladimir Temchura (321102)
- Klaus Überla (68531)
- Alberto Clivio (34840)
- Manuela Nebuloni (34846)
- Eleonora Lauri (34839)
- Daria Trabattoni (34837)
- Francisco Veas (34845)
- Mario Clerici (34848)
Publication date
February 2013
DOIAbstract
<p>The anti-HIV-1 antibody production in mouse sera is shown at days 0 (T0), 14 (T1 and 28 (T2) from each of the following immunized mice groups: HIV-1-VLP<sub>IIIB</sub>-CCL28, HIV-1-VLP<sub>IIIB</sub>-CCL19, HIV-1-VLP<sub>IIIB</sub>, CCL28 alone, CCL19 alone and control (saline)-treated mice. Levels of anti-HIV-1/Env-specific IgG (<i>A</i>) and anti-HIV-1/Env-specific IgA (<i>B</i>) in sera. The data are expressed as the mean ± SD (n = 5 mice per group) from three independent experiments. Statistically significant differences between groups and the reference HIV-1-VLP<sub>IIIB</sub>-CCL28 group are indicated.</p
Add to ORKG